Argyll Biotechnologies LLC

This profile gathers the share dealings of Argyll Biotechnologies LLC in Immunosyn Corp. Between 26 April 2007 and 13 March 2008, the trades on record add up to 23 filings.

The open-market side counts 2 purchases for €3.6B alongside 19 sales for €7.5B. The totals exclude 5 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2010, the count stands at no purchases and 3 sales.

The newest entry dates from 15 April 2010: a transaction, in Immunosyn Corp. The most recent open-market purchase was published on 4 September 2007, 7,005 days ago. Typically, a trade is published a median of 13 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.